A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...

Affordable, regulated versions of Ozempic, the well-known diabetes and weight-loss shot from Novo Nordisk, are about to hit markets around the world, which could shake up the obesity drug scene. The ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Lupin has received the Food and Drug Administration’s permission for tolvaptan tablets, 15 mg, 30 mg, 45 mg, 60 mg and 90 mg. Tolvaptan tablets are the generic of Otsuka’s Jynarque. Lupin is the ...

Abstract: We introduce LFL (language features library), a library composed by generic specification classes written in object-oriented action semantics. Object-oriented action semantics is a new ...

SHANGHAI, Feb 9 (Reuters) - China's healthcare regulator on Sunday defended the efficacy of off-patent medicines it had approved to be distributed through the country's public hospitals, saying an ...

AstraZeneca has launched new lawsuits against four generic drug manufacturers in an ongoing patent battle over its cancer drug Lynparza (olaparib), approved to treat ovarian, pancreatic, prostate, and ...

The journey of Takeda’s gout med Uloric—which turned rocky in recent years—has come to an end in the U.S. This week, the medicine, first approved in 2009, was listed as discontinued on the FDA’s ...

The cost of generic drugs for many people could go up if President-elect Donald Trump follows through on his promise to impose sweeping tariffs on products from China and other foreign countries, ...